4 Unique Challenges of Oncology Trials
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.
Oncology trials face unique hurdles in innovation, enrollment, and endpoints, requiring strategic planning to address complex study demands and precision needs.
Gene therapy research requires both IRB and IBC oversight—while IRBs protect participants, IBCs ensure community and environmental safety with local site-specific reviews.
The study startup process is a critical point in research, and oftentimes, can make or break a study’s success.
In today’s world of research, using a clinical trial management system (CTMS) can significantly streamline operations, and make for a
Clinical research aims to produce knowledge in the service of treating diseases and improving human health. In a just and
Effective participant recruitment is crucial to a successful clinical trial, and as trials become more complex, the problem is intensifying.
The use of engineered genetic materials in clinical trials is rapidly expanding, with potential applications for genetic vaccines, gene-modified cellular
While regulatory management takes time and effort, using an eRegulatory system can help staff boost productivity, improve compliance, and save resources.
Having a one in four chance of developing sickle cell disease (SCD) is uniquely, and overwhelmingly, familiar to the African
In an effort to accelerate the sharing of biomedical research results, the National Institutes of Health (NIH) issued its finalized
Metrics in general are one of the ways we can gauge how well a program or service delivers. In the
Medicare coverage analysis offers clinical sites a clear billing framework, protecting participants and minimizing financial risks for research studies.